HIV-1 auxiliary regulatory protein Vpr promotes ubiquitination and turnover of Vpr mutants containing the L64P mutation (Q40570314)

21 September 2017

title

HIV-1 auxiliary regulatory protein Vpr promotes ubiquitination and turnover of Vpr mutants containing the L64P mutation (English)

1 reference

21 September 2017

main subject

protein ubiquitination

1 reference

Ling-Jun Zhao

1

1 reference

21 September 2017

Heng Jian

series ordinal

2

1 reference

21 September 2017

Henghu Zhu

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

563

1 reference

21 September 2017

issue

1-3

1 reference

21 September 2017

page(s)

170-178

1 reference

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Pro-apoptotic Activity of HIV-1 Auxiliary Regulatory Protein Vpr Is Subtype-dependent and Potently Enhanced by Nonconservative Changes of the Leucine Residue at Position 64

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Specific gene inhibition by adenovirus-mediated expression of small interfering RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Emerging roles of ubiquitin in transcription regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Targeting of protein ubiquitination by BTB–Cullin 3–Roc1 ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Mechanisms underlying ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Virology. Weapons of mutational destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

T Cell Apoptosis Causes Peripheral T Cell Depletion in Mice Transgenic for the HIV-1 vpr Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Human immunodeficiency virus vpr gene encodes a virion-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

7 January 2021

Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

7 January 2021

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

7 January 2021

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

7 January 2021

Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

7 January 2021

Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900299-6

7 January 2021

10.1016/S0014-5793(04)00299-6

Identifiers

DOI

1 reference

21 September 2017

1 reference